Overweight in pregnancy
100 results
1 - 100
Overweight in pregnancy 
Cycling during pregnancy reduced the rate of GDM in overweight and obese women- Changes in smoking during pregnancy and risks of adverse birth outcomes and childhood overweight
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes- Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese: Cochrane systematic review
- Hormonal contraceptives for contraception in overweight or obese women
- Gestational diabetes mellitus (GDM)
- Hormonal contraception in overweight or obese women
- Energy/protein restriction for high weight-for-height or weight gain during pregnancy: Cochrane systematic review
- Maternal obesity and infant outcomes
- Psychosocial interventions for supporting women to stop smoking in pregnancy
- Fetal movement counts not useful to screen for fetal compromise
- Lifestyle modification for polycystic ovary syndrome
- Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
- Nutritional advice for improving outcomes in multiple pregnancies
- Meralgia paraesthetica
- Fertility counselling
- Carpal tunnel syndrome (CTS)
- Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese
- Polycystic ovary syndrome (PCOS)
- Interventions for preventing excessive weight gain during pregnancy
- Diet or exercise, or both, for preventing excessive weight gain in pregnancy
- Hypothyroidism
- Maternal obesity associated with neural tube defects
- Gynaecological prolapses
- Combined diet and exercise interventions for preventing gestational diabetes mellitus
- Routine weighing during pregnancy does not prevent excessive weight gain
- Diet or exercise, or both, for weight reduction in women after childbirth
- Contraception: initiation, choice of method and follow-up
- Diet and/or exercise for pregnant women for preventing gestational diabetes mellitus
- Probiotics for preventing gestational diabetes
- Pregnant women who become ill with COVID-19 are more likely to die and have adverse perinatal and neonatal outcomes
- Definition and diagnosis of dyslipidaemias
- Exercise for pregnant women for preventing gestational diabetes mellitus
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Overweight and obesity in children
- Care prior to and during subsequent pregnancies following stillbirth for improving outcomes
- Preconception myo-inositol and probiotics decrease premature birth
- Higher versus lower protein intake in formula‐fed term infants
- Infertility
- Obesity strongly associated with risk for stillbirth
- Abnormal menstrual bleeding
- Subdermal implants for contraception
- Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
- Antenatal clinics: care and examinations
- Systemic lupus erythematosus (SLE)
- Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health
- Insulin for the treatment of women with gestational diabetes
- Different insulin types and regimens for pregnant women with pre‐existing diabetes
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Risk of a venous thromboembolism during the postpartum period
- Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
- Type 1 diabetes: treatment
- Turner syndrome
- Buttock and hip pain
- Community‐based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews
- Polycystic kidney disease
- Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Pharmacological treatment of depression
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis